According to NeoGenomics 's latest financial reports the company's current earnings (TTM) are -$90.19 M. an increase over its 2022 earnings that were of -$0.16 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$90.19 M | -42.77% |
2022 | -$0.16 B | 54.74% |
2021 | -$0.11 B | 1347.28% |
2020 | -$7.04 M | -195.64% |
2019 | $7.35 M | -26.82% |
2018 | $10.05 M | 194.06% |
2017 | $3.41 M | 32.78% |
2016 | $2.57 M | -170.84% |
2015 | -$3.64 M | -263.89% |
2014 | $2.21 M | -30.1% |
2013 | $3.17 M | 161.8% |
2012 | $1.21 M | |
2010 | -$2.97 M | 71.51% |
2009 | -$1.73 M | 95.43% |
2008 | -$0.89 M | -72.72% |
2007 | -$3.24 M | -5353.35% |
2006 | $0.06 M | -107.71% |
2005 | -$0.81 M | 9.7% |
2004 | -$0.73 M | 47.59% |
2003 | -$0.5 M | 700.47% |
2002 | -$0.07 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | $1.13 B | -1,352.91% | ๐บ๐ธ USA |
LabCorp LH | $0.77 B | -958.19% | ๐บ๐ธ USA |
RadNet RDNT | $0.10 B | -214.53% | ๐บ๐ธ USA |
Psychemedics PMD | -$3.44 M | -96.19% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -$9.61 M | -89.35% | ๐บ๐ธ USA |